Genus signs exclusive license for technology to combat BRD

Using gene editing, discovery blocks bacterial toxin that triggers lung inflammation and pneumonia characteristic of BRD.

Genus PLC, a global pioneer in animal genetics, announced that it has signed an exclusive worldwide license with Washington State University for patents and know-how targeting bovine respiratory disease (BRD) using gene editing technology.

BRD is a complex bacterial and viral infection that causes lung disease in cattle (particularly calves) and is often fatal. In the U.S. beef industry, BRD continues to be a primary cause of mortality, and the disease also contributes to losses in

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.